Details for Patent: 10,130,585
✉ Email this page to a colleague
Which drugs does patent 10,130,585 protect, and when does it expire?
Patent 10,130,585 protects LODOCO and is included in one NDA.
This patent has thirty-seven patent family members in twenty-five countries.
Drugs Protected by US Patent 10,130,585
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | 10,130,585 | ⤷ Subscribe | A METHOD OF TREATING CARDIOVASCULAR DISEASE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,130,585
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014255434 | ⤷ Subscribe | |||
| Australia | 2019201048 | ⤷ Subscribe | |||
| Australia | 2020294268 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
